References
- Rai K. R., Sawitsky A., Cronkite E. P., Chanana A. B., Levy R. N., Pasternack B. S. Clinical staging of chronic lymphocytic leukemia. Blood 1975; 46: 219
- French Cooperative Group on Chronic Lymphocytic Leukemia. Prognostic and therapeutic advances in chronic lymphocytic leukemia management: the experience of the French Cooperative Group. Seminaire Hematol. 1987; 24: 275
- Tura S., Finelli C., Visani G., Cavo M., Rizzi S., Grimaldi M., Bandini G., Rosti G., Ricci P., Motta M. R., Fogli M. Cyclosporine in CLL and non Hodgkin's lymphomas with bone marrow failure. 5th International Workshop on CLL. Sitges, Barcelona 1991
- Rai K. R., Sawitsky A. Alpha Interferon (afF) and Erythropoietin (Epo): studies on their potential role in therapy of B-cell chronic lymphocytic leukemia (CLL). 5th International Workshop on CLL. Sitges, Barcelona 1991
- Geisler C. H., Hou-Jensen K., Jensen O. M., Pedersen N. T. The CLL 2 study: lack of prognostic significance of histological bone marrow infiltration pattern. 5th International Workshop on CL. Sitges, Barcelona 1991
- Pangalis G. A., Reverter J. C., Boussiotis V. A., Montserrat E. Chronic lymphocytic leukemia in younger adults: preliminary results of a study based on 454 patients. 5th International Workshop on CLL. Sitges, Barcelona 1991
- Vuillier F., Claisse J. F., Vandenvelde C., Travade P., Magnac C., Chevret S., Desablens B., Binet J.-L., Dighiero G. Evaluation of residual disease in B-cell chronic lymphocytic leukemia patients with clinical and bone marrow remission by using CD5 CD19 markers and PCR study of gene rearrangements, (submitted)